| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8940810 | Hematology, Transfusion and Cell Therapy | 2018 | 5 Pages |
Abstract
Treatment of reagent red blood cells with dithiothreitol can be efficient and accessible to offset the interference of the anti-CD38 drug in pre-transfusion tests. The number of costly serological workups can be reduced by having stored dithiothreitol red blood cells with this proving to be a useful reagent for investigating anti-CD38.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Carolina Bonet Bub, Isabel Nagle dos Reis, Maria Giselda Aravechia, Leandro Dinalli Santos, Eduardo Peres Bastos, José Mauro Kutner, Lilian Castilho,